Abstract: The disclosure provides methods for resolving an inconclusive cytological assessment of clinically relevant cells in a sample obtained from a patient based on the cytological detection of an antibody binding to a diagnostic protein in the clinically relevant cells in the sample.
Type:
Grant
Filed:
May 20, 2019
Date of Patent:
July 19, 2022
Assignee:
Sienna Cancer Diagnostics Ltd
Inventors:
Minesh Lalla, Fabio Turatti, Sharyn Wilson
Abstract: The disclosure provides methods for resolving an inconclusive cytological assessment of clinically relevant cells in a sample obtained from a patient based on the cytological detection of antibody binding to telomerase in clinically relevant cells in the sample, wherein binding of the antibody to clinically relevant cells indicates the presence of malignant or cancerous cells.
Type:
Grant
Filed:
February 17, 2015
Date of Patent:
July 2, 2019
Assignee:
Sienna Cancer Diagnostics Ltd
Inventors:
Minesh Lalla, Fabio Turatti, Sharyn Wilson